Sponsor or institution

Clinical trials and research at Lepu Biopharma Co., Ltd.

• 7Clinical trials
• 1Country

Newest trials

All recruiting trials (7)

• Pucotenlimab plus Becotatug Vedotin in locally advanced resectable head and neck cancer

  This study tests whether giving Pucotenlimab with Becotatug Vedotin around surgery helps patients with resectable head and neck squamous cell carcinoma.

  Recruiting Phase 2 Lepu Biopharma Co., Ltd. · Beijing, Beijing Municipality and 14 other locations · NCT07586124

• MRG006A combination therapy in advanced hepatocellular carcinoma

  This study tests the safety and early effects of MRG006A given with immune therapy and VEGF-targeted treatment in adults with advanced liver cancer that cannot be surgically removed.

  Recruiting Phase 1/2 Lepu Biopharma Co., Ltd. · Beijing, Beijing Municipality and 7 other locations · NCT07479485

• Cretostimogene for BCG‑unresponsive high‑grade non‑muscle‑invasive bladder cancer

  This treatment will test cretostimogene plus n‑dodecyl‑β‑D‑maltoside in adults whose high‑grade non‑muscle‑invasive bladder cancer did not respond to BCG (carcinoma in situ with or without Ta/T1 tumors).

  Recruiting at 14 sites Phase 2 Lepu Biopharma Co., Ltd. · Beijing, Beijing Municipality and 13 other locations · NCT07283835

• MRG006A treatment for advanced solid tumors

  This will test whether the antibody–drug conjugate MRG006A is safe and can help adults with advanced solid tumors.

  Recruiting at 2 sites Phase 1/2 Lepu Biopharma Co., Ltd. · Beijing, Beijing Municipality and 1 other locations · NCT07093970

• MRG003 plus pucotenlimab versus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma

  This trial tests whether combining MRG003 with pucotenlimab works better than standard chemotherapy for people with recurrent or metastatic nasopharyngeal carcinoma who have had at least one prior systemic treatment.

  Recruiting Phase 3 Lepu Biopharma Co., Ltd. · Guangzhou, Guangdong · NCT06976190

• MRG003 vs cetuximab/methotrexate for RM-SCCHN after prior therapies

  This trial tests whether MRG003 can help people with recurrent/metastatic squamous cell carcinoma of the head and neck who have already tried PD-1 inhibitors and platinum therapy by comparing it to cetuximab plus methotrexate as a later-line treatment.

  Recruiting Phase 3 Lepu Biopharma Co., Ltd. · Shanghai, Shanghai Municipality · NCT05751512

• Treatment of EGFR-positive advanced or metastatic solid tumors with MRG003 and HX008

  This study is testing a new combination treatment for patients with advanced or metastatic solid tumors that have EGFR-positive markers to see how safe and effective it is.

  Recruiting Phase 1/2 Lepu Biopharma Co., Ltd. · Guangzhou, Guangdong and 1 other locations · NCT05688605

Quick answers

How many clinical trials run by Lepu Biopharma Co., Ltd. are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 3, Phase 3: 2, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →